Haematological malignancies Educational session

Oncolytic virus therapy: A novel immunotherapeutic approach in haematologic malignancies (ID 380)

Lecture Time
11:25 - 11:50
Speakers
  • Kah-Whye Peng (Rochester, NY, United States of America)
Room
Room A
Date
Fri, Dec 9, 2022
Time
11:00 - 12:30
Mini Oral session 1 Mini Oral session

Invited Discussant (ID 414)

Lecture Time
10:00 - 10:10
Speakers
  • Benjamin Besse (Villejuif, CE, France)
Session Name
Room
Room C
Date
Thu, Dec 8, 2022
Time
09:00 - 10:10
Next generation technologies for the optimal implementation of immunotherapy Special session

Q&A (ID 37)

Lecture Time
17:15 - 17:30
Speakers
  • Solange Peters (Lausanne, Switzerland)
Room
Room C
Date
Thu, Dec 8, 2022
Time
16:00 - 17:30
Novel clinical and translational insights in melanoma Educational session

Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma (ID 86)

Lecture Time
09:00 - 09:20
Speakers
  • Stephan Vagner (Villejuif, Cedex, France)
Room
Room A
Date
Thu, Dec 8, 2022
Time
09:00 - 10:30
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2 Industry satellite symposium

Emerging data for targeting IL-8, CXCR1, and/or CXCR2 as potential treatment options in solid tumors (ID 339)

Lecture Time
13:45 - 14:00
Speakers
  • Matteo Simonelli (Milan, Italy)
Room
Room A
Date
Thu, Dec 8, 2022
Time
13:15 - 14:15
Cancer vaccines: Promise or dead end? Controversy session

Introduction and first vote (ID 375)

Lecture Time
14:05 - 14:15
Speakers
  • Stephen P. Schoenberger (La Jolla, CA, United States of America)
Room
Room A
Date
Wed, Dec 7, 2022
Time
14:05 - 15:05
Vesalius talk: Overcoming the fear of leading: How to become a leader in your research group Young Oncologists (YO) session

Panelist (ID 409)

Lecture Time
14:00 - 14:00
Speakers
  • Nicolas Girard (Paris, France)
Room
Room K
Date
Thu, Dec 8, 2022
Time
13:15 - 14:00
Welcome to the ESMO Immuno-Oncology Congress 2022 and Award Opening session

Overcoming resistance to immunotherapy: Targeting innate immune cells (ID 28)

Lecture Time
13:25 - 13:50
Speakers
  • Nina Bhardwaj (New York, NY, United States of America)
Room
Room B
Date
Wed, Dec 7, 2022
Time
13:15 - 13:50
Shared and neoantigen vaccines and T cells Educational session

Lessons learned from dendritic cell vaccines (ID 368)

Lecture Time
09:25 - 09:50
Speakers
  • Lisa H. Butterfield (San Francisco, CA, United States of America)
Room
Room C
Date
Fri, Dec 9, 2022
Time
09:00 - 10:30
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2 Industry satellite symposium

Closing remarks and audience Q&A (ID 22)

Lecture Time
14:00 - 14:15
Speakers
  • Vincenzo Bronte (Verona, Italy)
Room
Room A
Date
Thu, Dec 8, 2022
Time
13:15 - 14:15
Joint ESMO-SITC Immunotherapy Primer Special session

Utilizing oncolytic virus as a new treatment modality (ID 76)

Lecture Time
10:10 - 10:30
Speakers
  • Ramon Alemany (Hospitalet de Llobregat, Spain)
Room
Room C
Date
Wed, Dec 7, 2022
Time
09:00 - 12:30
B cells as a therapeutic opportunity Educational session

Regulatory B cells in cancer (ID 104)

Lecture Time
12:00 - 12:20
Speakers
  • Claudia Mauri (London, United Kingdom)
Room
Room B
Date
Thu, Dec 8, 2022
Time
11:00 - 12:30